No products in the cart.
![[Physician Comment] The extent of C. difficile infections may not differ in light of immune status](https://2minutemedicine-wpengine.netdna-ssl.com/wp-content/uploads/2012/11/x800px-Clostridium_difficile_01-e1353335581537.jpg.pagespeed.ic_.We5DxZl6Ye-350x250.jpg)
Oral microbiome therapy reduced Clostridioides difficile recurrence
1. SER-109, an oral microbiome therapy, showed superiority over placebo in reducing the recurrence of C. difficile infection. 2. SER-109 ...
Tag: Vancomycin
#VisualAbstract: Afabicin is non-inferior to vancomycin and linezolid for staphylococcal skin and soft tissue infections
1. Afabicin, a novel, narrow-spectrum antibiotic, was found to be non-inferior to vancomycin and linezolid in treating staphylococcal skin and ...
Quick Take: Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials
Several recently published guidelines regarding the treatment of C. difficile infection recommend vancomycin as first-line antibiotic treatment. However, given the ...
![Weekly dalbavancin noninferior to daily therapy for acute skin infection [DISCOVER 1 and 2 Trials]](https://2minutemedicine-wpengine.netdna-ssl.com/wp-content/uploads/2014/06/MRSA-aureus-350x250.jpg)
Weekly dalbavancin noninferior to daily therapy for acute skin infection [DISCOVER 1 and 2 Trials]
1. Once-weekly dalbavancin was not inferior to twice-daily vancomycin and linezolid in treating acute bacterial skin infection. 2. Fewer adverse ...
Vancomycin superior to metronidazole for severe C. difficile diarrhea [Classics Series]
Image: PD 1. Metronidazole and vancomycin had similar efficacy in treating mild cases of Clostridium difficile-associated diarrhea (CDAD). 2. Vancomycin ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.